Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 NOK)

NET PROFIT (x1000 NOK)

EMPLOYEES

Share

Meribel Pharma Solna AB

Closing information (x1000 NOK)

Closing information 2024/12 2023/12 2022/12
Turnover 107,590 More Arrow 121,636 Less Arrow 88,403
Financial expenses 3,211 Less Arrow 2,944 Less Arrow 1,530
Earnings before taxes -20,212 More Arrow 9,882 Less Arrow -7,623
EBITDA -16,342 More Arrow 13,765 Less Arrow -4,300
Total assets 75,898 Less Arrow 66,659 Less Arrow 46,368
Current assets 57,642 Less Arrow 50,459 Less Arrow 29,237
Current liabilities 37,954 Less Arrow 33,165 Less Arrow 20,931
Equity capital 37,945 Less Arrow 33,494 Less Arrow 25,437
- share capital 52 Less Arrow 51 Less Arrow 47
Employees (average) 73 Less Arrow 69 Less Arrow 62

Financial ratios

Fiscal year 2024/12 2023/12 2022/12
Solvency 50.0% More Arrow 50.2% More Arrow 54.9%
Turnover per employee 1,474 More Arrow 1,763 Less Arrow 1,426
Profit as a percentage of turnover -18.8% More Arrow 8.1% Less Arrow -8.6%
Return on assets (ROA) -22.4% More Arrow 19.2% Less Arrow -13.1%
Current ratio 151.9% More Arrow 152.1% Less Arrow 139.7%
Return on equity (ROE) -53.3% More Arrow 29.5% Less Arrow -30.0%
Change turnover -16,239 More Arrow 26,960 Less Arrow -6,382
Change turnover % -13% More Arrow 28% Less Arrow -7%
Chg. No. of employees 4 More Arrow 7 Less Arrow -2
Chg. No. of employees % 6% More Arrow 11% Less Arrow -3%

Total value of public sale

Fiscal year 2024/12 2023/12 2022/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.